Flynn James E

Average Profitability
<0.0001%
Insider Buys Quantity
69
Insider Buys Sum
$592.93M
Insider Sells Quantity
81
Insider Sells Sum
$226.16M

Insider Activity of Flynn James E

According to the SEC Form 4 filings, Flynn James E, being in a position of

  1. *Possible Member of 10% Group at AdaptHealth Corp.,
    оver the last 12 months, has bought 0 shares, and sold 350000 shares for $3.82M,
    over all time since 2024-03-08, has bought 0 shares, and sold 350000 shares for $3.82M.

The largest purchase of all time was on 2014-08-05 and amounted to 2668934 shares of Adverum Biotechnologies, Inc. for $63.85M.

The largest sale of all time was on 2024-10-22 and amounted to 1000000 shares of Nuvalent, Inc. for $97.75M.

Biography of Flynn James E

No biography is available at this moment.

2024-11-12SaleARS Pharmaceuticals, Inc.
SPRY
10 percent owner
34,814
0.0432%
$17.49$609,064-17.76%
2024-11-11SaleARS Pharmaceuticals, Inc.
SPRY
10 percent owner
528,456
0.6761%
$18.04$9.53M-21.61%
2024-10-22SaleNuvalent, Inc.
NUVL
* Director by deputization
1M
1.3662%
$97.75$97.75M0%
2024-09-17PurchaseBicara Therapeutics Inc. Common Stock
BCAX
Possible Members of 10% Group
35,000
0.045%
$18.00$630,000-22.31%
2024-03-12SaleAdaptHealth Corp.
AHCO
*Possible Member of 10% Group
114,906
0.0832%
$10.70$1.23M-5.08%
2024-03-11SaleAdaptHealth Corp.
AHCO
*Possible Member of 10% Group
182,607
0.1361%
$11.02$2.01M-5.25%
2024-03-08SaleAdaptHealth Corp.
AHCO
*Possible Member of 10% Group
52,487
0.0387%
$10.93$573,652-5.25%
2024-02-16PurchaseLarimar Therapeutics, Inc.
LRMR
* Director by Deputization
4.29M
6.6831%
$8.74$37.5M-40.61%
2022-11-03PurchaseNuvalent, Inc.
NUVL
director
650,000
1.388%
$33.50$21.77M+32.21%
2022-11-03PurchaseNuvalent, Inc.
NUVL
director
1.3M
2.776%
$33.50$43.55M+32.21%
2022-09-16PurchaseLarimar Therapeutics, Inc.
LRMR
11.11M
49.2054%
$3.15$35M+21.88%
2021-10-26PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
387,500
1.4134%
$16.00$6.2M-76.08%
2021-08-02PurchaseNuvalent, Inc.
NUVL
600,000
0.7259%
$8.50$5.1M-23.21%
2021-07-09SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
198,650
0.6325%
$15.81$3.14M+11.25%
2021-07-07SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
13,674
0.045%
$15.87$216,993+14.33%
2021-07-06SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
98,478
0.322%
$16.20$1.59M+11.07%
2021-07-02SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
21,198
0.0709%
$17.01$360,599+7.82%
2021-06-30PurchaseLarimar Therapeutics, Inc.
LRMR
685,710
3.341%
$8.75$6M-2.39%
2021-06-01PurchaseSingular Genomics Systems, Inc.
OMIC
10 percent owner
1.5M
3.3473%
$22.00$33M-62.91%
2021-05-04PurchaseWerewolf Therapeutics, Inc.
HOWL
10 percent owner
800,000
4.4986%
$16.00$12.8M-12.48%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.